English EN Spanish ES French FR Chinese (Simplified) ZH-CN

Breast Cancer Clinical Trials

Breast Cancer Clinical Trials

We’re here for you. Call us at 844-346-7222 or

Clinical Trials for Breast Cancer Treatments

Since 1989, breast cancer death rates have been decreasing thanks to advancements in treatment and earlier detection. At Regional Cancer Care Associates, we’re proud to be pioneers in the improvement of breast cancer treatments through our clinical trials. If you’re interested in enrolling in a breast cancer clinical trial, call RCCA today at 201-669-4706.

What Are Clinical Trials?

Before a new drug, medical strategy, or device can be approved, it first must be evaluated for human use. This research process is called a clinical trial. As scientific studies, clinical trials are methodically designed to follow strict scientific standards. At the end of each trial, the data is used to determine if the new medical therapy is a safe and effective method for improving patient outcomes.

Why Should I Enroll in a Breast Cancer Clinical Trial?

If you’ve been diagnosed with breast cancer, a clinical trial can give you access to the latest advancements and innovations in treatment methods and medications. In turn, you’ll participate in a research process that may one day help improve the quality of life for thousands of women and men around the world.

It’s important to note that clinical trials are one of the final stages of a careful research process that’s been developed and tested in laboratories for a significant amount of time before being offered to humans. For your safety, all clinical trials are closely monitored by an institutional review board and scientific experts.

Before agreeing to enroll in a breast cancer clinical trial, RCCA specialists require informed consent. This means that you’ll receive in-depth information about the trial, including treatments being used, its purpose, and possible risks and benefits, prior to enrollment. And as far as the cost of care goes, you won’t need to pay a penny. The company sponsoring the clinical trial will cover the bill, making clinical trials an affordable option for those diagnosed with breast cancer.

Breast Cancer Clinical Trials at RCCA

Your wellness and safety is placed above all else at RCCA. That’s why our clinical trials start with a personalized plan. To learn if you’re a good candidate for a breast cancer clinical trial, schedule an appointment with an RCCA cancer care physician today.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

10 Clinical Trials
Breast Cancer Clinical Trials Phase II Active
nct/study# NCT04720664 / OASIS

OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer.

Learn More
Breast Cancer Clinical Trials Ib/II Accepting Patients
nct/study# NCT03424005 / CO40115 - Morpheus TNBC

A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc)

Learn More
Breast Cancer Clinical Trials Ib/II Active
nct/study#  NCT04802759 / CO42867 - Morpheus BC

A Phase Ib/Ii, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Treatment Combinations In Patients With Breast Cancer (Morpheus-Breast Cancer)

Learn More
Breast Cancer Clinical Trials Phase II Accepting Patients
nct/study# NCT02400658 / BREAST-IORT

A Prospective Multi-Site Single- Arm Phase II Study To Investigate Breast IORT – The Efficacy Of Single-Fraction Intraoperative Radiation Treatment Using A Multi-Lumen Balloon Applicator And In-Room CT Imaging For The Treatment Of Early-Stage Breast Cancer.

Learn More
Breast Cancer Clinical Trials Phase II Accepting Patients
nct/study# NCT03487666 / 2017-1535-CA209-8CL

OXEL: A Pilot Study Of Immune Checkpoint Or Capecitabine Or Combination Therapy As Adjuvant Therapy For Triple Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy

Learn More
Breast Cancer Clinical Trials NA Accepting Patients
nct/study# NA / U01-COTA-DATABASE

Optimizing Personalized Care Using Economic Studies Of Genomic Testing

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.